Latest News
FairJourney Biologics Listed in Deloitte Fast 500
We are pleased to announce that FairJourney Biologics has been named as one of the 500 fastest-growing EMEA tech companies in the Deloitte Technology Fast 500 with FairJourney ranking 293 recognising the company's 439 percent growth. Full list can be found...
FairJourney Biologics joins forces with Iontas to create a global leader in outsourced antibody discovery services
• FairJourney’s combination with Iontas creates a leading global antibody discovery Clinical Research Organisation (‘CRO’) with an international footprint • FairJourney’s unique antibody discovery libraries and service portfolio to be complemented by Iontas’...
Leading global antibody discovery companies FairJourney Biologics and Iontas announce partnership in search for SARS-CoV-2 treatment
16 April 2020 • Bringing together complementary services and technology to allow faster identification of effective antibodies with a higher chance of success in development FairJourney Biologics (Porto, Portugal) and Iontas (Cambridge, UK) today announce a...
IONTAS announces Mammalian Display licensing agreement with Bristol Myers Squib
IONTAS’ mammalian display technology facilitates the identification of high affinity developable full-length antibody libraries in the context of mammalian cells Cambridge, UK – 13 October 2020 – IONTAS Limited (IONTAS), an innovative biotechnology company focused on...
